Burzynski Research Institute Inc.
BZYR
Burzynski Research Institute, Inc. (the Company ) was incorporated under the laws of the State of Delaware in 1984 in order to engage in the research, production, marketing, promotion and sale of certain medical chemical compounds composed of growth-inhibiting peptides, amino acid derivatives and organic acids which are known under the trade name Antineoplastons. The Company believes Antineopla…
Valuation & Multiples
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
$0.00
Net Income (TTM)
-$1M
▼ -3.8% YoY
Op. Margin
–
ROIC
–
Cash Flow & Balance Sheet
FCF
N/A
Op. Cash Flow (TTM)
-$258K
▲ +25.8% YoY
Net Debt
-$2K
Net Cash Position
Cash & Equiv.
$2K
Continue Research
Peers
In Vitro & In Vivo Diagnostic Substances · Pick stocks to compare with BZYR
Burzynski Research Institute (BZYR) in three numbers
Questions about Burzynski Research Institute
Is Burzynski Research Institute a high-quality business?
Burzynski Research Institute scores 18 out of 100 on Intrinsiqq's quality score, which makes it a lower-quality business on these measures. The score blends 2 checks computed from SEC filings. Its best check is net debt at -$2165, and its weakest is share count change at 0.0%. The Quality tab shows every check against its target.
Does Burzynski Research Institute (BZYR) pay a dividend?
No. Burzynski Research Institute (BZYR) does not pay a dividend, and no dividend payment appears anywhere in the filing history we hold. Nor has its share count fallen meaningfully over the last twelve months, so cash is kept in the business. The Dividends tab shows its cash returns.
Source: 10-Q filed 13 Jan 2026 (period ending 30 Nov 2025), SEC. Price: last close 19 Nov 2026. How this is calculated. Sector medians are approximate S&P 500 benchmarks and update periodically. Analysis, not investment advice.
Spot a number that looks wrong? Check it in BZYR's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing BZYR
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.